10x Genomics, an American biotechnology company celebrated the grand opening of its Singapore manufacturing facility and commercial hub recently.
A life sciences leader focused on mastering biology to advance human health, the opening of its Singapore’s facility is part of its major Asia Pacific (APAC) expansion. The Singapore manufacturing facility is also its first outside the US.
It occupies more than 53,000 square feet of the Solaris@Kallang 164 complex and includes state-of-the art, automated production suites for reagent manufacturing and a fully equipped, Biosafety Level-2 lab for training customers and partners on all 10x Genomics’ single cell and spatial technologies. Initial operations in late 2020. The site also includes a distribution center, supporting warehouse space and open office areas that encourage collaboration and teamwork.
The new addition is part of 10X Genomics’ ongoing investments to integrate and scale its operations network to build a more robust supply chain that will enable them to better serve their customers globally.
The Singapore facility will also serve as the APAC commercial hub, strengthening the company’s in-region sales, marketing and customer support capabilities.
According to 10x Genomics, Singapore is selected as the ideal location for its expansion because of the Singapore government’s demonstrated commitment to the biotechnology industry and business-friendly practices, world-class manufacturing expertise and strong talent pool.
“Singapore is a global hub for biotechnology with a thriving innovation ecosystem and strong research community,” said Serge Saxonov, Co-founder and CEO of 10x Genomics. “We sincerely thank the Economic Development Board of Singapore for their incredible support and partnership and the 10x teams in Singapore and California for their tremendous efforts in bringing this site online. We are thrilled to grow our presence here and are excited to contribute to Singapore’s culture of science and innovation as we work to fulfill the promise of this Century of Biology.”
“10x Genomics’ Singapore manufacturing facility and commercial hub will be a vibrant addition to our life sciences ecosystem, and we look forward to continuing our strong partnership with the company. The life sciences sector is an important pillar of our Healthcare industry and has a promising growth trajectory. The Economic Development Board remains committed to supporting innovation and manufacturing activities in this sector, which will create good jobs and business opportunities in Singapore,” said Ms. Goh Wan Yee, Senior Vice President and Head, Healthcare, Singapore Economic Development Board.
10x Genomics currently employs more than 80 employees in Singapore in manufacturing, corporate functions and commercial roles.